Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more
Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more
Singapore: Physicians treating rare blood disorders now have more drug treatments to choose from to treat patients. This in turn allows... Read more
Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithKline has announced... Read more
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical trial of its lead cancer... Read more
Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate... Read more
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterprise has released a... Read more
Singapore: GVK Biosciences is extending its Clinical Biomarker Database (Gobiom) license to the Biomarker Qualification Group of the US... Read more
Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical development anti-OX40... Read more
Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus on drug discovery... Read more
Singapore: A new report by healthcare experts GlobalData has revealed that on cytomegalovirus (CMV), which is generally asymptomatic in... Read more
Survey Box